[go: up one dir, main page]

WO2005092365A3 - Pharmaceutical use of novispirins - Google Patents

Pharmaceutical use of novispirins Download PDF

Info

Publication number
WO2005092365A3
WO2005092365A3 PCT/DK2005/000211 DK2005000211W WO2005092365A3 WO 2005092365 A3 WO2005092365 A3 WO 2005092365A3 DK 2005000211 W DK2005000211 W DK 2005000211W WO 2005092365 A3 WO2005092365 A3 WO 2005092365A3
Authority
WO
WIPO (PCT)
Prior art keywords
novispirins
pharmaceutical use
infections
novispirin
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK2005/000211
Other languages
French (fr)
Other versions
WO2005092365A2 (en
Inventor
Kristensen Hans-Hen Hoegenhaug
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Publication of WO2005092365A2 publication Critical patent/WO2005092365A2/en
Publication of WO2005092365A3 publication Critical patent/WO2005092365A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to use of Novispirin antimicrobial polypeptides in preparation of a pharmaceutical composition suitable for use against microbial lung infections or skin infections or for use in promoting wound healing.
PCT/DK2005/000211 2004-03-29 2005-03-29 Pharmaceutical use of novispirins Ceased WO2005092365A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200400503 2004-03-29
DKPA200400503 2004-03-29
DKPA200401288 2004-08-26
DKPA200401288 2004-08-26

Publications (2)

Publication Number Publication Date
WO2005092365A2 WO2005092365A2 (en) 2005-10-06
WO2005092365A3 true WO2005092365A3 (en) 2006-04-27

Family

ID=34962014

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2005/000211 Ceased WO2005092365A2 (en) 2004-03-29 2005-03-29 Pharmaceutical use of novispirins

Country Status (1)

Country Link
WO (1) WO2005092365A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000839A2 (en) * 2000-06-28 2002-01-03 The Regents Of The University Of California Statement as to federally sponsored research

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000839A2 (en) * 2000-06-28 2002-01-03 The Regents Of The University Of California Statement as to federally sponsored research

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BARTLETT KAREN H ET AL: "Novispirin G10-induced lung toxicity in a Klebsiella pneumoniae infection model.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 47, no. 12, December 2003 (2003-12-01), pages 3901 - 3906, XP002351530, ISSN: 0066-4804 *
SAWAI MONALI V ET AL: "Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides", PROTEIN ENGINEERING, vol. 15, no. 3, March 2002 (2002-03-01), pages 225 - 232, XP002335929, ISSN: 0269-2139 *
STEINSTRAESSER LARS ET AL: "Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 46, no. 6, June 2002 (2002-06-01), pages 1837 - 1844, XP002351531, ISSN: 0066-4804 *

Also Published As

Publication number Publication date
WO2005092365A2 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
EP2279662A3 (en) 5,7,4'-trihydroxy-3',5'-dimethoxyflavone as an antibacterial agent
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
IL199835A (en) Acid activated antimicrobial peptides, pharmaceutical compositions comprising the same and use thereof for the preparation of medicaments
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
WO2005020896A3 (en) N,n-dihalogenated amino acids and derivatives
BRPI0810958A2 (en) "composition, method of curative or preventive control of crop phytopathogenic fungi and use of composition"
WO2006087543A8 (en) Antibacterial piperidine derivatives
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
WO2006059234A3 (en) Bicyclic amides as kinase inhibitors
IL177283A (en) Pyrazolopyrimidine compounds, use thereof for the preparation of medicaments and pharmaceutical compositions comprising same
WO2005034883A3 (en) A method of healing skin wounds in mammals and a composition therefor
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
EP2540301A3 (en) Methods and pharmaceutical compositions for healing wounds
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
CL2007003332A1 (en) COMPOUNDS DERIVED FROM CONDENSED HETEROCICLES; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE PREVENTION OR TREATMENT OF BACTERIAL INFECTIONS.
IL181634A (en) Topical pharmaceutical compositions comprising 8-pyrazolylmethyl-1,3,7-trihydropurine-2,6-dione derivatives useful for wound healing
IL189270A (en) Phosphonated rifamycins and derivatives thereof, pharmaceutical compositions comprising the same and uses thereof in the preparation of medicaments for the prevention and treatment of bone and joint infections
WO2007030666A3 (en) Medicated skin care preparation for promoting wound healing
WO2008071961A8 (en) 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
WO2007028012A3 (en) Antibacterial 6'-n-modified 4,5-substituted aminoglycoside analogs
CL2004001012A1 (en) COMPOUNDS DERIVED FROM MACROLIDS OF 14 OR 15 MEMBERS, REPLACED IN POSITION 4 "; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF SYSTEMIC MICROBIAL OR TOPICAL INFECTIONS
WO2007071965A3 (en) Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
ZA200606606B (en) Substituted Azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
WO2007009701A3 (en) Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase